Yu Fujiwara

13PUBLICATIONS
39CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 17, 2026
Infusion-Related Reactions from Immune Checkpoint Inhibitors in Solid Tumors: A Proportional and Network Meta-Analysis.

|Feb 20, 2026
Evolving Trends in Latin American Participation in Global Oncology Clinical Trials: A Decade of Phase III Activity (2013-2022).

Rodrigo Paredes de la Fuente, Alexander B Karol, Anneliese Markus

|Sep 26, 2025
Documentation of patient withdrawals, retention strategies, and postwithdrawal data practices in cancer clinical trials.

Alexander B Karol, Rodrigo Paredes, Anna Argulian

|Apr 09, 2025
Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: A Phase II Study.

Sarbajit Mukherjee, Yu Fujiwara, Christos Fountzilas

|Nov 22, 2024
Safety and Efficacy of Osimertinib in Patients With Non-Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-Analysis.

Jonathan N Priantti, Yu Fujiwara, Francisco Cezar Aquino de Moraes

|Oct 11, 2024
Pancreatitis in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.

Mako Koseki, Yoshito Nishimura, Evelyn Elias

Pageof 3

Frequent Collaborators

3 joint publications

Nobuyuki Horita

3 joint publications

Alexander B Karol

3 joint publications

Himanshu Joshi

2 joint publications

Deborah B Doroshow